Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

NCT05089279 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure

Interventions

DRUG: D113
DRUG: CKD-349

Sponsor

Chong Kun Dang Pharmaceutical